» Articles » PMID: 30208377

The Latent Structure of Negative Symptoms in Schizophrenia

Overview
Journal JAMA Psychiatry
Specialty Psychiatry
Date 2018 Sep 13
PMID 30208377
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Negative symptoms are associated with a range of poor clinical outcomes, and currently available treatments generally do not produce a clinically meaningful response. Limited treatment progress may be owing in part to poor clarity regarding latent structure. Prior studies have inferred latent structure using exploratory factor analysis, which has led to the conclusion that there are 2 dimensions reflecting motivation and pleasure (MAP) and diminished expressivity (EXP) factors. However, whether these conclusions are statistically justified remains unclear because exploratory factor analysis does not test latent structure. Confirmatory factor analysis (CFA) is needed to test competing models regarding the latent structure of a construct.

Objective: To evaluate the fit of 4 models of the latent structure of negative symptoms in schizophrenia using CFA.

Design, Setting, And Participants: Three cross-sectional studies were conducted on outpatients with schizophrenia who were rated on the 3 most conceptually contemporary measures: Scale for the Assessment of Negative Symptoms (SANS), Brief Negative Symptom Scale (BNSS), and Clinical Assessment Interview for Negative Symptoms (CAINS). Confirmatory factor analysis evaluated the following 4 models: (1) a 1-factor model; (2) a 2-factor model with EXP and MAP factors; (3) a 5-factor model with separate factors for the 5 domains of the National Institute of Mental Health consensus development conference (blunted affect, alogia, anhedonia, avolition, and asociality); and (4) a hierarchical model with 2 second-order factors reflecting EXP and MAP and 5 first-order factors reflecting the 5 consensus domains.

Main Outcomes And Measures: Outcomes included CFA model fit statistics derived from symptom severity scores on the SANS, BNSS, and CAINS.

Results: The study population included 860 outpatients with schizophrenia (68.0% male; mean [SD] age, 43.0 [11.4] years). Confirmatory factor analysis was conducted on each scale, including 268 patients for the SANS, 192 for the BNSS, and 400 for the CAINS. The 1- and 2-factor models provided poor fit for the SANS, BNSS, and CAINS as indicated by comparative fit indexes (CFIs) and Tucker Lewis indexes (TLIs) less than 0.950, RMSEAs that exceeded the 0.080 threshold, and WRMRs greater than 1.00. The 5-factor and hierarchical models provided excellent fit, with the 5-factor model being more parsimonious. The CFIs and TLIs met the 0.95 threshold and the 1.00 threshold for both factor models with all 3 measures. Interestingly, the RMSEAs for the 5-factor model and the hierarchical model fell under the 0.08 threshold for the BNSS and the CAINS but not the SANS.

Conclusions And Relevance: These findings suggest that the recent trend toward conceptualizing the latent structure of negative symptoms as 2 distinct dimensions does not adequately capture the complexity of the construct. The latent structure of negative symptoms is best conceptualized in relation to the 5 consensus domains. Implications for identifying pathophysiological mechanisms and targeted treatments are discussed.

Citing Articles

Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping.

Mucci A, Leucht S, Giordano G, Giuliani L, Wehr S, Weigel L Brain Sci. 2025; 15(1).

PMID: 39851450 PMC: 11764445. DOI: 10.3390/brainsci15010083.


Intermittent theta burst stimulation for negative symptoms in schizophrenia patients with mild cognitive impairment: a randomized controlled trail.

Li J, Mo X, Jiang D, Huang X, Wang X, Xia T Front Psychiatry. 2025; 15():1500113.

PMID: 39831061 PMC: 11739303. DOI: 10.3389/fpsyt.2024.1500113.


Social network reductions are associated with negative symptoms in schizophrenia.

Zhang L, James S, Standridge J, Condray R, Allen D, Strauss G Soc Psychiatry Psychiatr Epidemiol. 2024; .

PMID: 39658696 DOI: 10.1007/s00127-024-02804-0.


The moderating role of COMT gene rs4680 polymorphism between maladaptive metacognitive beliefs and negative symptoms in patients with schizophrenia.

Fekih-Romdhane F, Kerbage G, Hachem N, El Murr M, Haddad G, Loch A BMC Psychiatry. 2024; 24(1):831.

PMID: 39567927 PMC: 11577635. DOI: 10.1186/s12888-024-06275-0.


A transdiagnostic approach of negative symptoms in psychiatric disorders: replication of a two-factor structure in major depressive disorder and bipolar disorder.

Li S, Zhang J, Liu C, Wang L, Hu H, Chu M Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 39488640 DOI: 10.1007/s00406-024-01934-5.


References
1.
Grube B, Bilder R, Goldman R . Meta-analysis of symptom factors in schizophrenia. Schizophr Res. 1998; 31(2-3):113-20. DOI: 10.1016/s0920-9964(98)00011-5. View

2.
Buchanan R, Javitt D, Marder S, Schooler N, Gold J, McMahon R . The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry. 2007; 164(10):1593-602. DOI: 10.1176/appi.ajp.2007.06081358. View

3.
Arndt S, Alliger R, Andreasen N . The distinction of positive and negative symptoms. The failure of a two-dimensional model. Br J Psychiatry. 1991; 158:317-22. DOI: 10.1192/bjp.158.3.317. View

4.
Hayduk L, Littvay L . Should researchers use single indicators, best indicators, or multiple indicators in structural equation models?. BMC Med Res Methodol. 2012; 12:159. PMC: 3506474. DOI: 10.1186/1471-2288-12-159. View

5.
Kirkpatrick B, Fenton W, Carpenter Jr W, Marder S . The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006; 32(2):214-9. PMC: 2632223. DOI: 10.1093/schbul/sbj053. View